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Abstract
The spontaneous mouse waved I (wal) mutation is
allelic with the transforming growth factor a (TGF-a)
gene and produces phenotypes similar to those of
TGF-a knockout mice. Here, we show that TGF-a
mRNA and protein levels are measurable in wal
tissues but reduced 5- to 30-fold relative to wild type.
Because the wal-coding sequence is identical to that
of the normal mRNA, wal is not a null mutation.
Nuclear run-on analyses revealed decreased
transcription of the TGF-a gene in wal tissues, but the
sequence of a 3.2-kb 5’ flanking fragment containing
the promoter was unaltered. Moreover, pulsed field gel
electrophoresis analysis did not reveal alterations
within 750 kb upstream or 350 kb downstream of the
gene, and chromosome 6 was karyotypically normal.
Hence, we speculate that the wal mutation may be
subtle and/or reside at a greater distance from the
TGF-a gene.
TGF-a deficiency elicits a spectrum of variably
penetrant eye anomalies in wal and knockout mice
that are associated with open eyes at birth. We found
that late-gestation wal and TGF-a-null embryos
display a significant delay in eyelid closure, although
the eyes of most embryos fuse prior to birth. In situ
hybridization localized TGF-a expression to the
advancing margins of the eyelid epithelium and
epidermal growth factor receptor expression
throughout the eyelid and comeal epithelia. These
results suggest that eye problems observed in TGF-a-
deficient adult mice arise from premature exposure
and trauma to open eyes during or following
parturition.
Introduction
Polypeptide growth factors exert pleiotropic effects on cells
to regulate such diverse activities as proliferation, differenti-
ation, migration, adhesion, and apoptosis. These processes
are crucial in ensuring normal formation and function of
multicellular organisms. The importance of growth factor
action to mammalian development and physiology has been
substantiated and elucidated by the study of mice that han-
bon either sporadic mutations or disruptions engineered via
gene targeting in embryonic stem cells. Typically, these
mouse mutants suffer from partial on complete loss of func-
tion of the affected gene, resulting in a deficit in a growth
factor, its receptor, or a substrate or effector molecule in-
volved in signal transduction (reviewed in Ref. 1). The phe-
notypes of these mutants range from mild to lethal and often
reveal tissue- or cell-specific functions of a growth factor
and/on its receptor. For example, various mutations at the W
or Steel (SI) loci, which encode, respectively, the receptor
tynosine kinase c-kit and its ligand, impair stem cells required
for melanogenesis, hematopoiesis, and gametogenesis (2,
3). The osteopetrosis (op) mutation causes truncation of
macrophage colony-stimulating factor, the ligand for the c-
fms receptor tyrosine kinase (4). Mice deficient in platelet-
derived growth factor B chain or its ￿3 receptor die perinatally
of renal and hematological disorders (5, 6). Targeted macti-
vation of neuregulin on its receptors, erbB2 on erbB4, results
in similar embryonic lethal phenotypes due to aberrant car-
diac and neural development (7-9). Finally, the phenotype of
EGFR3 knockout mice varies from early embryonic to pen-
natal lethal depending on the strain background, with sun-
viving neonates retarded in growth and impaired in epithelial
development in multiple organs (10-12).
3 The abbreviations used are: EGFR, epidormab growth factor receptor￿
TGF-a, transforming growth factor a; wal and wa2, waved 1 and 2
mutants, respectively; PFGE, pulsed field gel ebectrophoresis; RT, reverse
transcription; PMSF, phenylmethylsulfonyl fluoride; UT, untranslated;
poly(A)￿, polyadenylated; MGF, mast cell growth factor; RIA, radioimmu-
noassay; PCR, polyrnerase chain reaction; RFLP, restriction fragment
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We (13) and others (14) have used gene targeting to gen-
erate lines of mice devoid of TGF-a, one of several structur-
ally related ligands ofthe EGFR (recently reviewed in Ref. 15).
Although TGF-a is expressed in numerous embryonic and
adult tissues, mice lacking TGF-a were viable and fertile.
However, all homozygous null mice developed wavy fur and
whiskers, accompanied by disorientation of the hair follicles
and malformations of the hair shafts. TGF-a-deficient mice
also displayed eye abnormalities of variable incidence and
severity, including open eyes at birth, reduced size, and
superficial opacity. Histological examination of affected eyes
revealed eyelid and anterior segment dysgenesis, comeal
inflammation and fibrosis, and occasional lens and retinal
defects.
The spontaneous mouse mutants wal and wa2 were his-
tonically noted to display hair and eye defects strikingly sim-
ilar to those of TGF-a-targeted mice (16-19), and these
mutations, respectively, map to the vicinity of the TGF-cr and
erbB (EGFR) genes on mouse chromosomes 6 and 11 (20-
22). Recently, we (23) and others (24) showed the wa2 phe-
notype to be the result of a point mutation in the EGFR
tyrosine kinase that significantly impairs its enzymatic activ-
ity. Although crosses between mutant and targeted mice
confirmed that wal and TGF-a behave as alleles (13, 14), the
nature and location of the wal mutation have not yet been
identified. To understand the molecular basis of the wal
defect, we characterized and compared the murine TGF-a
transcript and promoter from normal and wal mice and
screened for alterations of the TGF-a gene. In addition, fur-
then studies were conducted to determine the etiology of the
eye defects in wal and TGF-a-targeted mice.
Results
Expression of Unaltered TGF-a Is reduced in wal Tis-
sues. We previously noted that TGF-a mRNA levels were
reduced in wal brain and liver compared with the corre-
sponding wild-type mouse tissues (1 3). We have now ex-
tended this observation to more broadly compare TGF-a
mRNA and protein levels in adult wild-type and wal mice. As
shown in Fig. 1A, the levels of the 4.5-kb TGF-a transcript
were consistently reduced in wal tissues relative to the
wild-type counterparts (Fig. 1A, top). These differences were
not due to unequal loading of the RNA samples, as demon-
strated by equivalent intensity of hybridization to the y-actin
probe (Fig. 1A, bottom). Interestingly, the difference between
wild-type and wal TGF-a mRNA levels varied depending on
the tissue. Although the levels of TGF-a mRNA were approx-
imately 5- to 8-fold higher in normal skin, kidney, and lung
than in the corresponding mutant tissues, this ratio was
roughly 30-fold in brain and decidua.
To address the possibility that the wal mutation could also
affect the translation and/or stability of the protein, we used
a specific RIA to quantitate TGF-a in selected wild-type and
mutant tissues. Fig. lB illustrates that, in contrast to TGF-a
knockout mice, wal mice contained measurable TGF-a.
When normalized to total lysate protein content, the TGF-a
concentrations of the three tissues compared were (+/+
versus wal): liver, 120.6 versus 12.2 pg/mg protein; brain,
622.9 versus 51 .8 pg/mg protein; and kidney, 39.5 versus 9.1
pg/mg protein. These decreases in wal TGF-a levels, which
ranged from 5- to 12-fold, were generally consistent with the
corresponding decreases in mRNA levels.
To determine whether the TGF-a protein produced in wal
mice is normal, we cloned wild-type and mutant cDNAs from
adult mouse brains by RT and PCR amplification. A compar-
ison of these sequences revealed that the coding regions
were identical. Because wal mice synthesize low levels of
normal TGF-a protein, the defect is not a null mutation. The
nucleotide sequence of the entire wild-type mouse TGF-a
transcript, which has not been reported previously, is shown
in Fig. 2. The coding sequence agrees with that reported
previously for a short PCR product (25) and is highly homol-
ogous to that of rat (26) and human (27) pro-TGF-a. The
predicted amino acid sequence also confirms an amino-
terminal peptide sequence previously obtained from the pu-
rifled 6-kilodalton murine TGF-a (28). Three amino acid dif-
ferences (Fig. 2, *) between mouse and rat TGF-a all lie
outside the mature 50-amino acid growth factor (Fig. 2, black
box). Additionally, the long 3’ UT sequence of the mouse
mRNA is 85% identical to the corresponding nat sequence
and includes several AUUUA motifs that have been impli-
cated in the regulation of mRNA stability. However, the pres-
ence of a distinct canonical polyadenylation signal (AAUAAA)
predicts that the mouse transcript is 0.5 kb shorter prior to
polyadenylation. The use of this poly(A)￿ signal was con-
firmed by hybridizing Northern blots of neonatal mouse skin
RNAs to probes located immediately upstream and down-
stream of this site: the TGF-a transcript was only detected
with cDNA probes located 5’ to this poly(A)￿ signal (data not
shown). Furthermore, using a common forward anchoring
primer and reverse primers located either 5’ or 3’ to the
putative poly(A)￿ site, RT-PCR products were obtained ex-
clusively with the reverse primer located upstream of the
poly(A)￿ site (data not shown).
wal TGF-a Gene Transcription Is Reduced, but the
Promoter Is Not Mutated. To investigate the mechanism
responsible for decreased TGF-a expression in wal mice,
we performed transcription rate measurements using the
nuclear run-on assay (29, 30). Nuclei from normal and wal
mutant tissues (brain and decidua) were transcribed in vitro,
and the resulting 32P-labeled, nascent transcripts were hy-
bridized to denatured, filter-bound DNA probes. TGF-a
probe a was a 1.6-kb fragment from intron 3, whereas probe
b was a 1.5-kb fragment located at the 5’ end of exon 6. The
specificity for TGF-a was verified by the lack of hybridization
to the parental plasmid pGEM4Z. Using either probe a or b,
TGF-a gene transcription was readily detectable in wild-type
nuclei but negligible in wal nuclei (Fig. 3). Scanning laser
densitometry and phosphoimager analysis of the signals ob-
tamed with decidua transcripts hybridized to probe b mdi-
cated that the rate of transcription along the TGF-a gene was
reduced at least 3-5-fold in wal versus wild-type nuclei. In
contrast, ractin and a-tubulin genes were comparably tran-
scnibed in mutant and wild-type nuclei.
The preceding analyses demonstrated that the decrease in
TGF-a expression in wal tissues is accompanied by reduced
TGF-cx gene transcription. We speculated that the wal mu-
tation might influence transcription initiation. To investigateA
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Fig. 1. TGF-a mRNA and protein expression in tissues from wild-type and wal mice. A, poly(A)￿ RNAs (10 ￿g, brain and decidua; 5 ￿g, skin and kidney;
4 1.Lg, lung) were resolved by ebectrophoresis through 1% agarose-formaldehyde gels, transferred to nylon membranes, and hybridized sequentially with
a 32P-labeled mouse 1.5-kb HindlIl TGF-a genomic clone corresponding to the exon 6 sequence (top) and a human 1.6-kb XhoI y-actin cDNA (bottom).
B, RIA of tissue extracts. Lysates were prepared to yield 11% wet weight tissues per volume. Increasing volumes of liver, brain, and kidney extracts from
wild-type (+1+), wal, and TGF-a-targoted homozygous null (-I-) mice were tested for their ability to compete with 1251-TGF-a for binding to a
TGF-a-specific IgG. DOtted line, synthetic rat TGF-a (1-500 pg/assay). #{149}, +1+; #{149} , wal; 0, -I--.
this mechanism, we first isolated and characterized the
mouse TGF-a promoter, which has not been described pre-
viously. A munine genomic library was screened with a 0.6-kb
HindlIl-Xbal fragment corresponding to the rat TGF-a pro-
moter (31 ). A resulting 20-kb mouse genomic clone was
further digested to produce a 3.2-kb NheI fragment that
hybridized to the rat Hindlll-Xbal probe. As shown in Fig. 4,
this fragment contains the pno-TGF-a translation start site
near its 3’ end, and 1 .8 kb of upstream sequence displays
89% homology to the rat TGF-a promoter and includes
consensus binding sites for several known transcription fac-
tons (Spi , AP2, Ets-1 , NFKB, PEA3, Oct-2, and APi). More-
over, this Nhel fragment directed expression of a coupled
lucifenase reporter gene in transiently transfected cells as
effectively as the rat promoter (data not shown). To deter-
mine whether the wal defect lies within this promoter region,
we constructed a wal genomic library and isolated the con-
responding 3.2-kb Nhel fragment. The sequence of this frag-￿C￿￿CCCCC0C0CCCGCOGCG0COCGCQ￿CCOCGCOTQCAGCACCCT0COCWGGAAG
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Fig. 2. Nucbeotide sequence of a full-length mouse TGF-a cDNA (accession number U65016). The predicted sequence of the 159-amino acid pro-TGF-a
is shown with the region corresponding to the mature, secreted 50-amino acid growth factor, delineated by the black box. *, three amino acid alterations
between the mouse and rat precursor, which all fall outside the mature growth factor domain; the tyrosine (1) and two beucine (L) residues in mouse
pro-TGF-a are changed to alanine (A) and two valine (b’) residues, respectively. in rat pro-TGF-a. A consensus polyadenybation signal (MUAAA) in the 3’
UT region is underlined. The presence of a CACA repeated motif, which is also present in the 3’ UT region of the rat TGF-a gene, is marked by a dashed
underline. Motifs potentially relevant to mRNA stability, which include consensus AUUUA pentamers and a consensus nonamer [UUAUUUA(U/A)(U/A)] with
the AUUUA pentamer core, are boxed.brain decidua
I I I
wa-i WI wa-i Wt
Table 1. Eyelid closure in wild-type, wal, and TGF-a-null embryos
1￿
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Fig. 3. TGF-a gene transcription rates in nuclei from adult wild-type and
wal mouse tissues. Brain and decidua nuclei were isolated and used in
transcription reactions in vitro. The resulting 32P-labeled nascent RNAS
were hybridized to the indicated denatured DNA probes as described in
“Materials and Methods.” probe a, 1.6-kb BamHI/Kpnl genomic fragment
from intron 3 of the mouse TGF-a gene; probe b, 1.5-kb Hindbbl genomic
fragment comprised mostly of exon 6 of the mouse TGF-a gene. The
parental vector pGEM4Z and plasmids containing cDNA5 encoding y-ac-
tin and a-tubulin were used as controls.
ment from wal DNA was found to be identical to that of the
wild type, and it directed equivalent luciferase activity (data
not shown).
The wal Locus Does Not Display Gross Chromosomal
Aberrations. Conventional Southern blots of wild-type and
wal genomic DNA digested with 13 different enzymes and
hybridized to several different probes spanning the length of
the TGF-a gene did not reveal RFLPs within or immediately
adjacent to the gene (data not shown). To search for more
distant alterations, we performed Southern blot analysis of
genomic DNA resolved by PFGE using restriction enzyme
sites and probes shown in Fig. SA. There were no differences
in the mobility of fragments obtained by digestion of wild-
type and wal DNAs with 11 restriction enzymes and visual-
ized by hybridization to either 5’ or 3’ probes (Fig. 5, B and
C). In addition, a probe further downstream of the 3’ probe
shown in Fig. 5A detected SnaBI fragments of equivalent size
(365 kb) in wild-type and wal DNA (data not shown). These
results indicate that the wal defect is not due to a significant
size alteration or rearrangement within 750 kb upstream or
350 kb downstream of the TGF-cx gene.
To determine whether the wa 1 mutation is associated with
gross chromosomal abnormalities, we examined the
G-banded karyotype of a wal/+ heterozygote and found
both copies of chromosome 6 to be indistinguishable. Spe-
cifically, there was no evidence of a panacentnic inversion in
the middle segment to which the locus maps, a conclusion
reinforced by studies of meiotic spreads from spenmatocytes
and a failure to detect any dicentnic or acentnic chromatids,
which would have resulted from a crossover within such an
inverted segment (32).
Eyelid Fusion Is Consistently Delayed in wal- and TGF-
a-targeted Mice. Adult wal, particularly TGF-a-targeted,
mice have been reported to display a spectrum of variably
penetrant eye abnormalities (13, 14, 19). Because these are
often presaged by the observation of open eyes at birth, we
Embryos derived from timed matings between either wild-type (+1+),
wall, or targeted TGF-a-null mice (-I-) were isolated on the designated
days of gestation and inspected with a dissecting microscope to score for
eyelid closure. The numbers of litters represented by each age and gen-
otype are given in parentheses. At day El 5.5, all embryos of all genotypes
had open eyes.
Open-eyed embryos/total embryos
Genotype
DayEl6.5 Day E17.5
+1+ 0/31 = 0% (4 litters) N.D.a
wal/wal 26/26 = 100% (3 litters) 6/16 = 38% (3 litters)
-I- 65/73 = 89% (1 0 litters) 9/43 = 21 % (6 litters)
a ND., not determined.
(1 3) and others (14) hypothesized that the primary ocular
defect resulting from TGF-cr deficiency was a delay or failure
of prenatal eyelid growth and fusion. To test this hypothesis,
we examined eyelid closure in normal, wal, and TGF-￿-
targeted embryos during the period from days E15.5 to El 7.5
of gestation, when eyelid development normally proceeds. In
agreement with previous descriptions (33, 34), all eyes of
wild-type embryos were fully open at day El5.5 but com-
pletely closed at day El 6.5 (Table 1). In contrast, 100% of
wal embryos had open eyes at day E16.5, and although this
frequency had greatly diminished 1 day later at day El 7.5,
38% of wal embryos still had one or both eyes partially
open. A similar delay was observed with TGF-a knockout
embryos: 89% had variably open eyes at day El 6.5 (Fig. 6A),
and this frequency decreased to 21 % by day El 7.5 (Table 1).
Furthermore, in mixed-genotype litters derived from het-
erozygous intercrosses, all open-eyed embryos proved to be
homozygous null for TGF-a, but not all null embryos (<50%,
days El6.5 and El7.5) had open eyes (data not shown).
Histological analysis (Fig. 6B) demonstrated that eyelids of
wild-type embryos displayed fusion of the opposing epithelia
(Fig. 6B, a), whereas those of TGF-a-null embryos exhibited
variable extension across the cornea but no contact of the
opposing epithelia (Fig. 6B, b). A sampling of 10 mutant and
6 normal embryos revealed no evidence of inflammation
and/or deformation of the cornea, iris, lens, or retina, which
were observed postnatally in TGF-a-deficient mice (1 3, 14).
To further explore the role of TGF-a and its receptor in
eyelid development, we localized their expression by in situ
hybridization. Sections of wild-type embryo eyes were hy-
bnidized to antisense niboprobes specific for TGF-a and
EGFR. At day E15.5, TGF-a mRNA expression was concen-
trated at the advancing margins of the eyelid epithelium (Fig.
7, a and b, arrows). As shown in Fig. 7, c and d, opposing
eyelids have nearly closed by day E16, at which time TGF-a
expression was localized to the epidermal cells that bridge
the growing eyelids. At day El6.5, TGF-a hybridization was
restricted to the cells at the outermost bayer of lid fusion (Fig.
7, e and I). Additionally, TGF-a was expressed in the corneab
epithelium throughout this period of eyelid development (Fig.
7d). By comparison, the expression of EGFR mRNA (Fig. 8)
was much higher and more broadly distributed. At day El 5.5,
EGFR hybridization was particularly pronounced throughout
the entire epithelia of the eyelids (Fig. 8, a and b). At days El6AseI
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Fig. 4. Nucbeotide sequence of 3.2 kb of the murine TGF-a promoter region (accession number U64873). The sequence is numbered relative to the first
nucleotide of the presumptive translation initiation codon. The locations of restriction endonuclease sites are indicated. The amino acid sequence of a
portion of exon 1 is illustrated under the nucbeotide sequence. The region proximal to exon 1 was searched for consensus transcription factor-binding sites
using the FindPattems sequence analysis program and the Transcription factor sites data set file with no mismatches in the software package from Genetics
Computer Group (Madison, WI; version 8.0). Box, Spl; dashed underline, AP2; heavy underline, NF.cB; light underline, PEA3; 0-0, Ets-l and TCF-2a; 0
under sequence, Oct-2; ￿ under sequence, PEAl and APi.B
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Xhol-Nhel fragment of the mouse TGF-a promoter (see Fig. 2), whereas the 3’ probe was a 1.5-kb HindIll genomic fragment comprising mostly exon 6 of
the mouse TGF-a gene (see Fig. 4). A summary of the results from a series of Southem blots is shown. B and C, Southem blots of wild-type and wal DNA
digested with the indicated enzymes, subjected to a contour-clamped homogeneous electric field, blotted onto Zeta Probe membranes, and hybridized to
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Fig. 6. Comparison of eyelid development in wild-type and TGF-a-deficient embryos. A, wild-type (top) and TGF-a-null (bottom) embryos isolated at day
El 6.5. Note that the normal eyelids are closed, whereas the mutant eyelids exhibit variable extent of development. B, morphology of the anterior segment
of wild-type (a) and TGF-a-null (b) eyes. The eyelids of the targeted day El 6.5 embryo show the lack of growth and fusion. LE, lid epithelium; CE, comeal
epithelium; R, retina; L, lens. Arrow, eyelid fusion. Note that the comea, iris, lens, and retina of both genotypes appear normal. x 100.a
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Fig. 7. Expression of TGF-a during eyelid development. In situ hybrid-
ization of an antisense 35S-labeled TGF-a riboprobe to frozen sections
through the eyes of normal mouse embryos was performed as described
(47). Bright-field (a, c, and e) and dark-field (b, d, and I) views of sections
of day E15.5 (a and b), E16 (c and a), and E16.5 (e and f) embryos are
shown. Note that hybridization is concentrated in the epithelium at the
distal tips of the eyelids (arrows). Open arrowhead, refraction due to
pigment granules in the iris, not hybridization. LE, lid epithelium; CE,
comeal epithelium; I, iris. x200.
and El6.5, hybridization was also prominent in the corneal
epithelium and in all cells in between the eyelid margins.
Taken together, these spatial and temporal patterns of ex-
pression are entirely consistent with the genetic evidence
supporting a role for interactions between TGF2 and EGFR in
eyelid development.
Discussion
In this report, we provide further molecular analysis of TGF-a
deficiency in wal mice. Our results indicate that the wal
mutation affects the level of TGF-a mRNA rather than the
structure or activity of the TGF-a protein. The marked reduc-
tion in TGF-a mRNA levels is accounted for, at least in part,
by a significant decrease in transcription of the TGF-cr gene,
as measured by the nuclear run-on assay. Nevertheless, the
5’ flanking sequences of the wal and wild-type genes are
identical and exhibited comparable luciferase activity in cou-
pled promoter-reporter transient transfection assays. Addi-
tionally, Southern analysis of wal and wild-type DNAs re-
solved in conventional or PFGE gels did not disclose RFLPs,
gross deletions, or rearrangements within 750 kb upstream
or 350 kb downstream of the TGF-a gene, and chromosome
6 appeared normal on karyotype analysis. One possible ex-
planation is that the wa 1 defect is a subtle, internal mutation;
unfortunately, the large size of the TGF-cx gene (85-90 kb;
Fig. 8. Expression of EGFR during eyelid development. In situ hybrid-
ization of an antisense 35S-labeled EGFR riboprobe to frozen sections
through the eyes of normal mouse embryos was performed as described
(48). Bright-field (a, C, and e) and dark-field (b, d, and I) views of sections
of day El 5.5 (a and b), El 6 (C and a), and El 6.5 (e and I) embryos are
shown. Note that hybridization is prevalent throughout the epithelia of the
eyelids and the cornea. Open arrowhead, refraction due to pigment gran-
ules in the iris, not hybridization. LE, lid epithelium; CE, comeal epithelium;
I, iris.x200.
Ref. 31) precludes a comprehensive comparison. Alterna-
tively, the wal mutation may lie at a greater distance from the
gene and may elude detection by the present methods.
Several mouse mutations with long-range positional ef-
fects on gene expression have been described (reviewed in
Ref. 35). These include remote chromosomal alterations
(e.g. , translocations, inversions, and deletions) that either
activate or repress expression of proto-oncogenes, tran-
scniption factors, growth factors, and receptors. Often these
alterations exert tissue-specific effects on expression, as
observed with the wal mutation. For example, the Steel-
panda mutant allele results from an inversion of chromosome
10, with the breakpoint bocated 115 kb upstream of the
coding region of MGF (36). The decrease in MGF expression
in the ovary leads to impaired follicle development and fe-
male sterility. The W-sash mutant allele is also an inversion,
with the breakpoint mapping at greater than 100 kb up-
stream of the gene encoding the MGF receptor c-kit. (37).
This mutation enhances expression in some cell types and
represses it in others, suggesting that it may affect both
positive and negative regulatory elements. Positional effects
on gene expression may result from elimination of endoge-
nous regulatory sequences (e.g. , enhancers and silencers),
juxtaposition of exogenous regulatory sequences, or alter-
ations in chromatin conformation. Alternatively, an as yet12&l Wal TGF-a Gene Expression and Eyelid Development
unknown mechanism may be responsible for the wal defect.
Few, if any, examples of specific mutations exerting posi-
tional effects at a distance greater than 500 kb have been
described. This could reflect the ranity of their occurrence
and/or inherent limitations in the methods used in their char-
actenization.
Regardless of the mechanism underlying the wal defect,
the resulting reduction in TGF-a expression uniformly leads
to a developmental delay in eyelid growth and fusion that is
also observed in null embryos. These findings are consistent
with the localization of TGF-a mRNA to the tips of the ad-
vancing eyelids and underlying comeal epithelia of wild-type
embryos. This compartmentalization is intriguing given the
demonstrated ability of TGF-a to stimulate keratmnocyte pro-
liferation and migration (38). Judging by the pattern of ex-
pression of the receptor throughout the epithelia of the eyelid
and the cornea, TGF-a could act in either an autocnine or a
paracnine mode. Alternatively, the membrane-bound precur-
son pro-TGF-a might also function in a juxtacrine manner to
enable the advancing eyelid epithelium to adhere and move
across the adjacent corneal epithelium. Interestingly, nearly
all EGFR knockout mice that survive to birth also display the
open-eye phenotype (10-12). The higher incidence of the
open-eye phenotype with the loss of EGFR implies that other
EGFR ligands may also function in eyelid development and
may partially compensate for TGF-a deficiency.
Although delayed eyelid fusion affected virtually all mutant
embryos, the proportion with open eyes had markedly de-
creased by partunition; therefore, only a minority of knockout
mice and no wal mice were born with open eyes.4 The
absence of aberrant morphology in the other ocular com-
partments in late-stage mutant embryos suggests that the
eye problems observed in adult TGF-a-deficient mice arise
after birth. The subsequent ocular damage, which includes
corneal ulceration, inflammation and fibrosis, distortion of
the anterior segment, lens rupture on extrusion, and retinal
dysplasia, likely results from premature exposure of the eyes
to trauma and/or potential infection. Normally, the cornea,
iris, lens, and retina continue to differentiate after fusion of
the eyelids and formation of the conjunctival sac (33). Eyelid
closure may thus create an essential microenvironment for
late prenatal and early postnatal ocular development, as well
as providing protection for these underlying structures dun-
ing and following birth.
The phenotype of open eyes at birth has also been ob-
served in several other spontaneous and targeted mouse
mutants but is poorly understood. Inactivation of the genes
encoding the c-abl kinase (39) and the activin and inhibin ￿B
subunit (40) gives rise to some newbonns with open eyes.
Although these effects have not been further characterized,
penetrance in the latter study was found to depend on the
strain background, suggesting an influence of other modify-
ing genes. Surviving mutant mice also developed eye prob-
lems resembling those of TGF-a knockout mice. In addition,
4 In contrast to a published report with another wal stock (19), the ABP-Le
strain of wal mice from Jackson Laboratories does not typically exhibit
the open eyes at birth phenotype; this may reflect inbred strain differences
(N. Luetteke, personal observation).
deregulated expression of integrin aS and/or (31 transgenes
in suprabasal epidermal kenatinocytes led to the birth of mice
with open eyes that later developed comeal scarring and
wavy hair (41). This raises the interesting possibility that
TGF-a and integnins may interact in an antagonistic manner,
via modulation of expression or function, to regulate epithe-
hal proliferation and migration during eyelid and hair follicle
development. Current experiments are designed to test this
hypothesis.
Materials and Methods
Cloning and Sequencing. A 3.5-kb NheI fragment was subcboned from
a 20-kb Notb A genomic clone that was isolated from a mouse genomic
library (Stratagene, La Jolla, CA) using the rat HindIII-XbaITGF-a proximal
promoter fragment (31) as a hybridization probe. The wal genomic library
was prepared as described (31), using DNA isolated from brain. A full-
length mouse TGF-a cDNA sequence was deduced by analyzing multiple
clones derived from RT-PCR of mouse brain RNA (exons 1-5), as well as
overlapping fragments cloned from a mouse genomic library (exons 4-6).
Double-stranded plasmid DNAS were prepared by Qiagen (Chatsworth,
CA) purification. Automated Taq DyeDeoxy Terminator cycle sequencing
was performed with an Applied Biosystems 373A automated DNA se-
quencer at the University of North Carolina-Chapel Hill DNA Sequencing
Facility. Manual dideoxy DNA sequencing (42) confirmed ambiguous re-
gions obtained from automated sequencing. Mouse TGF-a-specific oh-
gonucleotide primers were synthesized on an Applied Biosystems 380B
DNA synthesizer using a 40-nm polystyrene column and desalted by a
Sep-Pak Plus Cl8 cartridge (Milhipore Corp., Milford, MA).
RNA Analyses. Total RNAS were purified (43), and their quality and
quantitation were confirmed by electrophoresis through 1% agarose-8 P4
urea gels. Poly(A)￿ RNAS were selected by chromatography on obigode-
oxythymidylic acid (44) and anaiyzed by Northern blot as described (45).
Probes were a nick-translated, 32P-Iabeled mouse 1.5-kb HindIll genomic
fragment or a 1.6-kb XhoI y-actin cDNA (pHF1 ; Ref. 46). In situ hybrid-
ization was performed on semiadjacent, fresh-frozen cryostat sections (10
i<M) as described previously (47, 48).
TGF-a-specific RIA. Uver, brain, and kidney lysates prepared from
wild-type, wal, and TGF-a-targeted homozygous null mica were meas-
ured for TGF-a protein using a nonequibibrium double-antibody RIA as
described previously (49). Chemically synthesized rat TGF-a was used for
both the tracer and standard (Peninsula Laboratories, Belmont, CA). The
specificity of the antibody has been extended to exclude cross-reactivity
with amphiregubin, heparin-bmnding EGF, and heregulmn f3l (data not
shown), as well as rat and mouse EGF, as reported previously. Results are
normalized to total protein concentration of the lysate (DC Protein Assay;
Bio-Rad, Hercules, CA).
Nuclear Transc#{241}ption Run-on Analysis. Nuclei were isolated from
adult brain and day 9.5 decidua, and transcription analyses were per-
formed as described previously (29, 30). Cells were disrupted in buffer
containing 0.1 % NP4O, and lysates were layered onto successive sucrose
cushions of 0.88 and 1.0 P4. Following centrifugation at 1500 x g at 4#{176}C for
10 mm, nuclear pellets were resuspended in 1 ml glycerol storage buffer
[50% glycerol, 20 mM Tris-CI (pH 7.5), 75 m￿ NaCI, 0.5 m￿ EDTA, 0.85 mp,i
DTT, 0.125 mM PMSF, and 100 units/mI RNasin] and counted using a
hemacytometer. After adjustment to approximately equivalent concentra-
tions, nuclei were aliquoted and stored in liquid nitrogen.
Prior to assay, thawed nuclei were pelbeted at 1000 X g at 4#{176}C,
resuspended in 110 ￿b reaction buffer [300 m￿ ammonium sulfate, 100 mrs
Tris-CI (pH 7.9), 4 mM MgCl2, 4 mrs MnCI2, 50 mr￿i NaCI, 0.4 mrs EDTA, 0.1
mM PMSF, 1.2 mM DTT, 1 mrs each dATP, dCTP, and dGTP, 10 mr.i
creatine phosphate, 10 ￿g/mlcreatine kinase, 20 units/mI RNase inhibitor,
29% glycerol, and 100-250 ￿Ci of [￿2PJUW per reaction) and incubated
at 30#{176}C for 30 mm. Reactions were terminated by the addition of 100 ￿.d
DNase I buffer [10 mM Tris-CI (pH 7.5), 10 m￿ MgCI2, 1 m￿ DTT, 100 ￿g
yeast tRNA, and 1700 units DNase I (171 .3 units/pi; Life Technologies,
Inc.)] and incubated at 37#{176}C for 10 mm. An equal volume of 2 x proteinase
K buffer [20 mM Tris-CI (pH 8.0), 20 mrs EDTA, 1 % SDS, and 200 pg/mI
proteinase K] was added, and samples were further incubated at 45#{176}C for
30 mm. Following extraction with phenol:chboroform:isoamyl alcohol (25:Cell Growth & Differentiation 1281
24:1), 32P-labeled RNAS were passed through Sephadex G-50 columns
and precipitated in 5% tnchloroacetic acid. After limited-base hydrolysis,
labeled RNAS were recovered by ethanol precipitation. Prior to hybridiza-
tion, the 32P-babeled RNA pellet was dissolved in hybridization buffer,
heated at 65#{176}C for 10 mm, and counted. Equivalent cpm in 500 ￿I were
then heated for 10 mm at 85#{176}C.
For analysis of nuclear transcription products, DNA probes were de-
natured and slotted onto either nitroceblubose or Nytran membranes
(Schleicher & Schuell, Keene, NH) using a Hoeffer slot blot apparatus.
Probes included a 1.6-kb BamHl-Kpnl TGF-a genomic fragment within
intron 3 (probe a), a 1.5-kb HindIll TGF-a genomic fragment encompass-
ing most of exon 6 (probe b), a 1.6-kb Xhol ‘y-actin fragmentfrom plasmid
pHFl (46), a 1.8-kb PstI a-tubulin fragment from plasmid praTub (a gift
from Frank Salomon), and the promoterless parental plasmid pGEM4Z as
a negative control. After binding DNAS, filters were UV cross-linked (1200
,.L￿J) using a Stratalinker 1800 (Stratagene) and incubated in prehybridiza-
tion buffer [50 mM HEPES (pH 7.6), 750 mos NaCI, 50% formarnide, 0.5%
SOS, 2 mM EDTA, lox Denhardt’s solution, 200 pg/mI sheared salmon
sperm DNA, and 10 pg/mI polyriboadenylic acid] for 16 h at 42#{176}C. Each
filter was then hybridized to equivalent cpm (l0￿-lO￿ cpm/ml) of 32P-
labeled nuclear transcripts for 48-72 h at 42#{176}C. Fiiters were subsequently
washed for 15 mm each fourtimes in 0.1 x SSC (2x SSC = 0.3 p￿ sodium
chloride and 0.03 M sodium citrate) and 0.1 % SDS at 55#{176}C, once in 2x
sSC containing 10 pg/mI RNaseAand 100 units/mI RNaseTl (Boehringer
Mannheim, Indianapolis, IN) at 37#{176}C, and twice in 0.1 x SSC and 0.1%
SDS at 55#{176}C.
PFGEAnalysIs. To prepare high molecularweight genomic DNA, cells
isolated from the spleens of two wal and two wild-type mice were
counted with a hemacytometer and resuspended to a concentration of
2 x 1o￿ cells/mb PBS. An equal volume of 1% Seaplaque agarose (FMC
Bioproducts, Rockland, ME)/PBS(42#{176}C)was added tothecebls and mixed
to form the plugs. Once solidified, the plugs were incubated in digestion
buffer [1 % N-lauryl-sarcosine, 0.5 M EDTA, 10 mrs Tris-CI (pH 8.5), and
200 pg/mI proteinase K] at 50#{176}C for 16 h, incubated three times for 1 h
each in T10E￿0 buffer [10 mr￿i Tris-CI (pH 8.0) and 50 mrs EDTA] at 25#{176}C,
incubated twice for 30 mm in T10E1 buffer containing 40 ￿g PMSF/mI at
55#{176}C, and stored in T10E￿ buffer at 4#{176}C. Two-mm gel slices from wild-
type and wal DNA preparations were equilibrated in 250 ￿J 1 x restriction
buffer overnight at room temperature. The buffer was replaced with fresh
buffer containing a 3-8-fold excess of the indicated restriction endonu-
clease. Following digestion, samples were ebectrophoresed through 1%
SeaKem LE agarose (FMC Bioproducts)/0.5x Tris-borate EDTA (lOx =
89 m￿ Tris-borate and 2 mM EDTA) gels using a CHEF-DR III contour-
clamped homogeneous electric field system (Bio-Rad, Melville, NY) at
14#{176}C for2O h underthe following conditions: 6V, initial switch time of3O s,
final switch time of 120 s, included angle of and 120 degrees. Gels were
stained with ethidium bromide, depunnated twice for 12.5 mm each in
0.25 M HCI, denatured twice in 1.5 M NaCVO.5 M NaOH for20 mm each and
once in 1 P4 NH4OAC/0.1 P4 NaOH for 30 mm, and transferred to Zeta Probe
(Bio-Rad). DNA was UV cross-linked to the membrane, baked at 80#{176}C in
vacuo for 1 h, and hybridized as described by the manufacturer.
Histology. For collection of mouse embryos from timed matings, the
morning the coital plug was found was defined as day 0.5 of gestation.
Adult mice were sacrificed by cervical dislocation or CO2 asphyxiation.
Embryos were removed and dissected in ice-cold PBS and fixed in 10%
buffered formalin or frozen unfixed in cryostat embedding medium (for in
situ hybridization). Fixed embryos were inspected and photographed
under a dissecting microscope and embedded in glycolmethacrylate.
Plastic sections(2 ￿m)were stained with methylene blue and acid fuchsin.
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